Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Critical Assessment of Phenotyping Cocktails for Clinical Use in an African Context. | J Pers Med | 2023 | 37511712 | PubTator, text mining | PubMed |
| Sertindole, an Antipsychotic Drug, Curbs the STAT3/BCL-xL Axis to Elicit Human Bladder Cancer Cell Apoptosis In Vitro. | Int J Mol Sci | 2023 | 37511611 | PubTator, text mining | PubMed |
| Programmed Cell Death Pathways in Cholangiocarcinoma: Opportunities for Targeted Therapy. | Cancers (Basel) | 2023 | 37509299 | PubTator, text mining | PubMed |
| Management of Polypharmacy and Potential Drug-Drug Interactions in Patients with Mycobacterial Infection: A 1-Year Experience of a Multidisciplinary Outpatient Clinic. | Antibiotics (Basel) | 2023 | 37508267 | PubTator, text mining | PubMed |
| The impact of IDH and NAT2 gene polymorphisms in acute myeloid leukemia risk and overall survival in an Arab population: A case-control study. | PLoS One | 2023 | 37478088 | PubTator, text mining | PubMed |
| Correlation of N-acetyltransferase 2 genotype and acetylation status with plasma isoniazid concentration and its metabolic ratio in ethiopian tuberculosis patients. | Sci Rep | 2023 | 37454203 | PubTator, text mining | PubMed |
| Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study. | Pharmgenomics Pers Med | 2023 | 37426898 | PubTator, text mining | PubMed |
| Induction of glucose production by heterocyclic amines is dependent on N-acetyltransferase 2 genetic polymorphism in cryopreserved human hepatocytes. | Toxicol Lett | 2023 | 37423373 | PubTator, text mining | PubMed |
| NAT2 phenotype alters pharmacokinetics of rivaroxaban in healthy volunteers. | Biomed Pharmacother | 2023 | 37385211 | PubTator, text mining | PubMed |
| Augmentation Therapies as Treatments for Coexisting Somatic Problems in Schizophrenia-A Systematic Review. | J Clin Med | 2023 | 37373704 | PubTator, text mining | PubMed |
| Clinical standards for the management of adverse effects during treatment for TB. | Int J Tuberc Lung Dis | 2023 | 37353868 | PubTator, text mining | PubMed |
| How Does Environmental and Occupational Exposure Contribute to Carcinogenesis in Genitourinary and Lung Cancers? | Cancers (Basel) | 2023 | 37345174 | PubTator, text mining | PubMed |
| Bladder cancer screening: The new selection and prediction model. | Open Med (Wars) | 2023 | 37333447 | PubTator, text mining | PubMed |
| Contrasting Effects of Temperature on Human Arylamine N-Acetyltransferase and Acetyl Coenzyme A Hydrolase Activities. | Biochemistry | 2023 | 37318062 | PubTator, text mining | PubMed |
| Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis. | Pharmacogenet Genomics | 2023 | 37306344 | PubTator, text mining | PubMed |
| N -acetyltransferase 2 haplotype modifies risks for both dyslipidemia and urinary bladder cancer. | Pharmacogenet Genomics | 2023 | 37306342 | PubTator, text mining | PubMed |
| Role of Vitamin D in Head and Neck Cancer-Immune Function, Anti-Tumour Effect, and Its Impact on Patient Prognosis. | Nutrients | 2023 | 37299554 | PubTator, text mining | PubMed |
| Etiopathogenesis and Emerging Methods for Treatment of Vitiligo. | Int J Mol Sci | 2023 | 37298700 | PubTator, text mining | PubMed |
| Pathways Related to Colon Inflammation Are Associated with Colorectal Carcinoma: A Transcriptome- and Methylome-Wide Study. | Cancers (Basel) | 2023 | 37296884 | PubTator, text mining | PubMed |
| Pharmacogenetics as part of recommended precision medicine for tuberculosis treatment in African populations: Could it be a reality? | Clin Transl Sci | 2023 | 37291686 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=13